Skip to content
10-Q

Quarterly Report

Artiva Biotherapeutics, Inc. ARTV

0000950170-25-104045

← back to feed
Filed
Aug 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 31, 2025 24.43M sh
Shares Diluted Q2 2025 · Jun 30, 2025 24.38M sh
Shares Diluted Q2 2025 · Jun 30, 2025 24.36M sh
Shares Diluted Q2 2025 · Jun 30, 2024 811.21K sh
Shares Diluted Q2 2025 · Jun 30, 2024 810.48K sh
Capex Q2 2025 · Jun 30, 2025 $1.57M
Capex Q2 2025 · Jun 30, 2024 $482K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$42.82M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$28.77M
Short Term Investments Q2 2025 · Jun 30, 2025 $113.9M
Short Term Investments Q2 2025 · Dec 31, 2024 $145.19M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $28.47M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $40.24M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $34.25M
Stockholders Equity Q2 2025 · Jun 30, 2025 $149.04M
Stockholders Equity Q2 2025 · Mar 31, 2025 $168.78M
Stockholders Equity Q2 2025 · Dec 31, 2024 $186.64M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$191.1M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$174.67M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$162.02M
Current Liabilities Q2 2025 · Jun 30, 2025 $10.77M
Current Liabilities Q2 2025 · Dec 31, 2024 $12.25M
Total Liabilities Q2 2025 · Jun 30, 2025 $20.35M
Total Liabilities Q2 2025 · Dec 31, 2024 $22.94M
Current Assets Q2 2025 · Jun 30, 2025 $149.07M
Current Assets Q2 2025 · Dec 31, 2024 $188.63M
Total Assets Q2 2025 · Jun 30, 2025 $169.39M
Total Assets Q2 2025 · Dec 31, 2024 $209.58M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.87
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.71
Eps Diluted Q2 2025 · Jun 30, 2024 −$22.00
Eps Diluted Q2 2025 · Jun 30, 2024 −$39.24
Eps Basic Q2 2025 · Jun 30, 2025 −$0.87
Eps Basic Q2 2025 · Jun 30, 2025 −$1.71
Eps Basic Q2 2025 · Jun 30, 2024 −$22.00
Eps Basic Q2 2025 · Jun 30, 2024 −$39.24
Sga Expense Q2 2025 · Jun 30, 2025 $4.95M
Sga Expense Q2 2025 · Jun 30, 2025 $10.07M
Sga Expense Q2 2025 · Jun 30, 2024 $3.86M
Sga Expense Q2 2025 · Jun 30, 2024 $7.44M
Rd Expense Q2 2025 · Jun 30, 2025 $17.86M
Rd Expense Q2 2025 · Jun 30, 2025 $34.91M
Rd Expense Q2 2025 · Jun 30, 2024 $12.33M
Rd Expense Q2 2025 · Jun 30, 2024 $23.49M
Net Income Q2 2025 · Jun 30, 2025 −$21.25M
Net Income Q2 2025 · Jun 30, 2025 −$41.57M
Net Income Q2 2025 · Mar 31, 2025 −$20.31M
Net Income Q2 2025 · Jun 30, 2024 −$17.84M
Net Income Q2 2025 · Jun 30, 2024 −$31.81M
Net Income Q2 2025 · Mar 31, 2024 −$13.96M
Operating Income Q2 2025 · Jun 30, 2025 −$22.81M
Operating Income Q2 2025 · Jun 30, 2025 −$44.98M
Operating Income Q2 2025 · Jun 30, 2024 −$16.19M
Operating Income Q2 2025 · Jun 30, 2024 −$30.68M